In vitro studies have suggested that BTKi therapy can suppress NOTCH1 activation via B-cell receptor–NOTCH1 interactions, providing a mechanistic rationale for these clinical results.

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

No significant toxicities observed in 11 patients included in study; 10 were alive at median follow-up of 2.6 years.

The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.

Despite no difference in event-free survival found between short and long preoperative chemo, long preoperative significantly increased CA19-9 response rate, N0 resection rate, number of the ...

The risk of lung cancer varies among responders involved in rescue and recovery after the collapse of the World Trade Center, a study suggests.

Researchers successfully developed a machine learning-based method for predicting symptom deterioration in patients with cancer.

Stephen Johnston, Ph.D., from the Royal Marsden NHS Foundation Trust in London, and colleagues reported the primary OS results for patients with HR-positive, HER2-negative, node-positive, high-risk ...

Survival benefits were seen in patients in rural or high-poverty communities, as well as in patients with a cancer generally linked to a worse prognosis, study researchers reported.

Despite SBRT to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

An overview of a financial navigation program and some key financial resources for patients with cancer that patients can be directed toward.

Key factors to develop to support a navigation program are determine the patient volume, develop a staffing model, and build financial stability.